Co-Amoxiclav 250/125mg is a widely prescribed, broad-spectrum antibiotic used to treat a variety of bacterial infections that do not respond to standard penicillin treatment alone. Each capsule contains 250mg amoxicillin and 125mg clavulanic acid, providing a dual-action formula designed to overcome resistant bacteria and support faster recovery.
This is a prescription only medicine.
5 in stock
Login to see pricesBroad-spectrum treatment for many common bacterial infections.
Enhanced effectiveness due to clavulanic acid, which helps overcome antibiotic resistance.
Trusted medication frequently prescribed in primary and specialist care.
Convenient capsule form for accurate dosing and ease of use.
Supports rapid symptom relief when taken as part of a prescribed course.
Strength: 250mg Amoxicillin / 125mg Clavulanic Acid
Format: Hard capsules
Pack Size: 21 capsules
Prescription-only medicine (POM)
Suitable for adults and children when prescribed by a clinician
Manufactured to UK/EU pharmaceutical standards
Co-Amoxiclav is often chosen when standard amoxicillin may not be enough on its own. The addition of clavulanic acid helps neutralise beta-lactamase enzymes produced by resistant bacteria, allowing the antibiotic to work effectively. This makes it a dependable choice for infections that have become persistent or more difficult to treat.
Healthcare professionals may prescribe Co-Amoxiclav 250/125mg for bacterial infections such as:
Respiratory tract infections (e.g., bronchitis, sinusitis)
Ear, nose and throat infections
Urinary tract infections (UTIs)
Skin and soft tissue infections
Dental infections
Bone and joint infections (when appropriate)
This list is not exhaustive; suitability depends on clinical assessment.
Co-Amoxiclav contains two active ingredients that work together:
Amoxicillin
A penicillin-type antibiotic that kills bacteria by preventing them from building protective cell walls.
Clavulanic Acid
A beta-lactamase inhibitor that stops resistant bacteria from destroying amoxicillin, making the antibiotic more effective against tougher infections.
Together, they form a powerful combination that targets a wide range of bacteria, including strains resistant to standard antibiotics.
